P

Inventor

MIRANDA LESLIE P

US25 patents
⚠️ This page may combine multiple inventors who share the name “MIRANDA LESLIE P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

20 patents
US8008453B2Aug 30, 2011

Modified Fc molecules

AMGEN INC55 citations97
US7833979B2Nov 16, 2010

Toxin peptide therapeutic agents

AMGEN INC45 citations95
US7803769B2Sep 28, 2010

OSK1 peptide analogs and pharmaceutical compositions

AMGEN INC46 citations95
US7834164B2Nov 16, 2010

DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression

AMGEN INC9 citations92
US10905772B2Feb 2, 2021

Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)

AMGEN INC6 citations82
US7820623B2Oct 26, 2010

Conjugated toxin peptide therapeutic agents

AMGEN INC10 citations82
US7825093B2Nov 2, 2010

Methods of using OSK1 peptide analogs

AMGEN INC4 citations73
US7910102B2Mar 22, 2011

Methods of using conjugated toxin peptide therapeutic agents

AMGEN INC4 citations72
US8043829B2Oct 25, 2011

DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression

AMGEN INC6 citations71
US11807693B2Nov 7, 2023

Apelin polypeptides

AMGEN INC0 citations62
US11266744B2Mar 8, 2022

Modified Fc molecules

AMGEN INC0 citations62
US10941182B2Mar 9, 2021

Apelin polypeptides

AMGEN INC0 citations61
US12214051B2Feb 4, 2025

Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)

AMGEN INC0 citations59
US11732266B2Aug 22, 2023

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

AMGEN INC0 citations57
US11643440B2May 9, 2023

Peptide PAC1 antagonists

AMGEN INC0 citations55
US10188740B2Jan 29, 2019

Modified Fc molecules

AMGEN INC0 citations51
US9796766B2Oct 24, 2017

Potent and selective inhibitors of NAV1.3 and NAV1.7

AMGEN INC0 citations48
US10870856B2Dec 22, 2020

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

AMGEN INC0 citations47
US9636418B2May 2, 2017

Potent and selective inhibitors of NAV1.7

AMGEN INC0 citations39
US10344060B2Jul 9, 2019

Potent and selective inhibitors of Nav1.7

AMGEN INC0 citations38

SULLIVAN JOHN K

1 patent

GEGG JR COLIN V

1 patent

MURRAY JUSTIN K

1 patent

GEGG COLIN V

1 patent

KANG SOHYE

1 patent